Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders
Status:
Terminated
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
Selective serotonin reuptake inhibitors (SSRIs) including sertraline have been found to be
effective in the treatment of generalized social phobia (GSP). However, virtually all of the
current treatment studies with medicines, including the SSRIs, have excluded patients with
social phobia who have other co-occurring conditions. In fact, 80% of individuals suffering
with primary social phobia have at least one other anxiety. This study will evaluate the
safety and efficacy of sertraline in the treatment of generalized social phobia with
co-occurring anxiety and mood disorders.